Topical Issues of the Efficiency and Safety of Using the First Direct Thrombin Inhibitor in Real Clinical Practice

Nevrologiya, Neiropsikhiatriya, Psikhosomatika - Russian Federation
doi 10.14412/2074-2711-2015-4-116-120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Effectiveness and Safety of Narlaprevir in Real Clinical Practice of Chronic Hepatitis C

Jurnal Infektologii
Infectious Diseases
2019English

Diagnostic Accuracy of a Novel Chromogenic Direct Thrombin Inhibitor Assay: Clinical Experiences for Dabigatran Monitoring

Thrombosis and Haemostasis
Hematology
2017English

Effects of the Oral, Direct Thrombin Inhibitor Dabigatran on Five Common Coagulation Assays

Thrombosis and Haemostasis
Hematology
2011English

Do Delays in Data Availability Limit the Implementation of Near Real-Time Vaccine Safety Surveillance Using the Clinical Practice Research Datalink?

Pharmacoepidemiology and Drug Safety
EpidemiologyPharmacology
2017English

Preanalytical Issues Identification and Prevention in Clinical Hematology Laboratory: Best Practice for Patient Safety

Tropical Journal of Pathology and Microbiology
2019English

Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer

Breast Care
SurgeryOncology
2016English

The Ph-Positive and Ph-Negative Myeloproliferative Neoplasms: Some Topical Pre-Clinical and Clinical Issues

Haematologica
Hematology
2011English

5psq-075 Safety Profile of Fingolimod in Real World Clinical Practice: A Preliminary Study

2020English

Efficacy, Safety and the Routine Use of First Generation SADs in Paediatric Practice

Anaesthesia
AnesthesiologyPain Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy